Search by Drug Name or NDC
NDC 63323-0407-04 Caffeine Citrate 20 mg/mL Details
Caffeine Citrate 20 mg/mL
Caffeine Citrate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is CAFFEINE CITRATE.
Product Information
| NDC | 63323-0407 |
|---|---|
| Product ID | 63323-407_6e710851-4ae5-46ba-811e-64d19f3e2ca6 |
| Associated GPIs | 61300010102020 |
| GCN Sequence Number | 043901 |
| GCN Sequence Number Description | caffeine citrate VIAL 60 MG/3 ML INTRAVEN |
| HIC3 | A1B |
| HIC3 Description | XANTHINES |
| GCN | 50748 |
| HICL Sequence Number | 000011 |
| HICL Sequence Number Description | CAFFEINE CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | Caffeine Citrate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CAFFEINE CITRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | CAFFEINE CITRATE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077997 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0407-04 (63323040704)
| NDC Package Code | 63323-407-04 |
|---|---|
| Billing NDC | 63323040704 |
| Package | 1 VIAL in 1 BOX (63323-407-04) / 3 mL in 1 VIAL |
| Marketing Start Date | 2009-11-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |